Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.95
-0.95 (-3.18%)
Mar 4, 2026, 11:53 AM CST

Apex Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,9893,0094,0282,5542,5992,354
Market Cap Growth
-4.47%-25.31%57.73%-1.73%10.38%-16.91%
Enterprise Value
2,5392,6673,8422,3372,2922,222
Last Close Price
29.9028.9337.5422.6521.9419.08
PE Ratio
19.9423.5034.7914.0512.8524.84
Forward PE
-13.8413.8413.8413.8413.84
PS Ratio
1.521.622.401.141.221.17
PB Ratio
1.651.652.241.411.481.43
P/TBV Ratio
1.681.692.301.461.581.55
P/FCF Ratio
14.5610.0119.32-16.9510.00
P/OCF Ratio
13.419.1517.4895.9514.458.39
EV/Sales Ratio
1.301.442.291.041.081.11
EV/EBITDA Ratio
11.7514.6518.608.997.8611.12
EV/EBIT Ratio
16.3620.7627.1113.2411.1821.50
EV/FCF Ratio
12.388.8818.43-14.959.44
Debt / Equity Ratio
0.060.070.090.100.160.31
Debt / EBITDA Ratio
0.520.640.710.670.952.48
Debt / FCF Ratio
0.540.410.74-1.862.18
Net Debt / Equity Ratio
-0.25-0.26-0.16-0.12-0.19-0.19
Net Debt / EBITDA Ratio
-2.18-2.61-1.41-0.83-1.17-1.55
Net Debt / FCF Ratio
-2.19-1.58-1.3921.76-2.22-1.31
Asset Turnover
0.840.790.700.870.800.73
Inventory Turnover
2.431.891.542.442.753.05
Quick Ratio
2.652.001.931.571.421.32
Current Ratio
4.083.443.932.902.241.91
Return on Equity (ROE)
8.43%7.07%6.40%10.16%11.90%5.70%
Return on Assets (ROA)
4.18%3.40%3.68%4.26%4.81%2.36%
Return on Invested Capital (ROIC)
10.26%7.53%7.49%10.65%14.91%6.26%
Return on Capital Employed (ROCE)
8.10%6.60%7.40%9.10%10.90%5.80%
Earnings Yield
5.06%4.25%2.87%7.12%7.78%4.03%
FCF Yield
6.87%9.99%5.18%-0.39%5.90%10.00%
Dividend Yield
3.99%4.15%2.93%6.18%5.93%5.76%
Payout Ratio
79.27%85.90%120.86%71.48%54.06%115.98%
Buyback Yield / Dilution
-0.17%-0.08%0.34%4.70%6.53%-0.05%
Total Shareholder Return
3.82%4.07%3.27%10.88%12.46%5.72%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.